查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1677163

按類型、行業應用和最終用戶分類的數位診斷市場 - 2025 年至 2030 年的全球預測

Digital Diagnostics Market by Type, Industry Applications, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計數位診斷市場規模在 2024 年將達到 15.4 億美元，在 2025 年將達到 16.3 億美元，複合年成長率為 6.17%，到 2030 年將達到 22.1 億美元。

主要市場統計數據
基準年 2024 年 15.4億美元
預計 2025 年 16.3億美元
預測年份 2030 22.1億美元
複合年成長率（%） 6.17％

在快速發展的醫療保健領域，數位診斷正在重新定義疾病的檢測和管理方式。人工智慧、影像技術和分子遺傳學的最新進展預示著一個變革時代的到來，診斷方法將變得越來越有效和精確。推動這項變革的是跨學科研究和技術突破的融合，將數位化功能與傳統診斷程序結合。技術開發人員和臨床醫生之間的策略互動正在催化創新，不僅可以最佳化診斷準確性，而且可以改善多種臨床條件下的患者治療結果。

在此背景下，從行業專家到醫療保健決策者的相關人員都在關注數位診斷在重塑患者護理途徑中發揮的關鍵作用。就像一場精心編配的交響樂，新的數位工具和傳統調查方法的融合正在創造一個未來，在那裡早期發現、個人化治療和改善疾病管理都是可以實現的目標。這些變化在快速診斷至關重要的環境中尤其重要，並為全球向資料主導的醫療決策奠定了基礎。

這項全面概述涵蓋了數位診斷市場的方面，並提供了有關市場趨勢、轉型轉變、細分分析、區域差異等方面的相關見解。接下來的章節將深入探討推動市場發展的市場催化劑，並深入說明這一重要領域所面臨的機會和挑戰。

重新定義數位診斷格局的轉型

過去幾年，數位診斷領域發生了前所未有的變化。新興技術正在彌合診斷成像、即時病患監測和精確分子分析之間的差距。最顯著的變化之一是高階分析技術擴大融入診斷業務。增強的成像技術和機器學習演算法現在是關鍵促進因素，可以實現更準確、更快的疾病識別。資料處理和雲端連接方面的創新也為不同地區和研究機構之間的更大合作鋪平了道路。

此外，行動醫療應用程式和先進診斷設備的整合正在促進向偏遠和服務不足的地區提供醫療服務。這項進步不僅使人們能夠更自由地使用尖端診斷工具，而且還縮短了從初次諮詢到明確診斷的時間。數位病理學、放射學和穿戴式健康監測系統現已成為旨在徹底改變傳統護理模式的生態系統的核心。隨著對研究的持續投入和強力的監管重點，市場正在見證向早期疾病檢測和個人化治療策略的穩步轉變。

隨著醫療保健產業從被動護理轉向主動護理，這些趨勢強調了擁抱數位轉型的重要性。資料科學與傳統診斷之間的協同效應正在創建一個可以適應新的健康威脅和不斷變化的患者需求的彈性框架，確保醫療保健服務的強勁和可擴展的未來。

揭示市場細微差別的關鍵細分洞察

詳細的細分分析為數位診斷市場的基本動態提供了細緻的觀點。按類型評估市場，廣泛的研究表明，它可以細分為數位皮膚病學、數位病理學、數位放射線、行動健康診斷、分子和基因診斷以及穿戴式和遠端監控。此分類強調了技術進步和數位方法日益融入診斷過程的各個方面。

此外，當我們研究行業應用時，我們發現數位診斷擴大影響心臟病學、感染疾病、神經病學和腫瘤學等領域的治療方式。這些領域不僅代表了廣泛的醫療保健挑戰，而且代表了透過提高診斷準確性和早期療育實現成長機會的重要領域。作為這些見解的補充，基於最終用戶屬性的細分確定了研究機構、診斷實驗室和影像中心、醫院和診所以及學術醫療中心所發揮的關鍵作用。每個細分市場都利用專門的數位工具來滿足特定的醫療保健需求，為整個市場做出了獨特的貢獻。

對細分市場的徹底分析將有助於更清楚地了解不斷變化的需求，並推動創新以解決需求驅動的診斷問題。因此，透過整合來自各個細分觀點的見解，相關人員可以更好地制定產品開發、市場進入策略和資源分配策略，以有效地將技術進步與臨床優先事項和患者護理標準結合起來。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 有利的政府政策和監管支持為數位診斷提供了重大推動力
      • 遠端醫療和遠端監控解決方案的廣泛採用將推動數位診斷的整合
      • 慢性病增多，需要早期發現和準確的診斷解決方案
    • 限制因素
      • 引進先進技術及訓練專業人員高成本
    • 機會
      • 透過數位診斷結合穿戴式科技開發個人化醫療
      • 建立策略夥伴關係和合作關係，利用先進的資料分析簡化數位診斷工作流程
    • 任務
      • 資料隱私問題與網路安全風險削弱消費者信任
  • 市場區隔分析
    • 類型：利用智慧型手機連接和行動裝置的行動醫療（行動醫療）診斷需求不斷成長
    • 最終用戶：數位診斷擴大應用於診斷實驗室和成像中心，以實現滿足這些嚴格要求的智慧主導分析。
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章 數位診斷市場按類型

  • 數位皮膚病學
  • 數位病理學
  • 數位放射線
  • 行動醫療（行動醫療）診斷
  • 分子和遺傳診斷
  • 穿戴式裝置和遠端監控

第7章 數位診斷市場按行業應用

  • 心臟病學
  • 感染疾病
  • 神經病學
  • 腫瘤學

第 8 章 數位診斷市場（按最終用戶）

  • 診斷實驗室和影像中心
  • 醫院和診所
  • 研究所和學術醫療中心

9. 美洲數位診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第 10 章：亞太地區數位診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第 11 章歐洲、中東和非洲數位診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭格局

  • 2024 年市場佔有率分析
  • FPNV 定位矩陣，2024 年
  • 競爭情境分析
  • 戰略分析與建議

公司列表

  • Abbott Laboratories
  • Agilent Technologies
  • Aidoc
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories
  • Butterfly Network, inc
  • CANON MEDICAL SYSTEMS CORPORATION
  • Carestream Health, Inc.
  • Danaher Corporation
  • FUJIFILM Holdings America Corporation
  • GE Healthcare Technologies, Inc.
  • Google LLC
  • Guardant Health, Inc.
  • Hologic, Inc.
  • International Business Machines Corp.
  • Invitae Corporation
  • Koninklijke Philips NV
  • Microsoft Corporation
  • NVIDIA Corporation
  • PathAI, Inc.
  • Qiagen NV
  • Roche Diagnostics Corporation
  • Siemens Healthineers
  • Tempus AI, Inc.
  • Thermo Fisher Scientific
Product Code: MRR-A40F58415944

The Digital Diagnostics Market was valued at USD 1.54 billion in 2024 and is projected to grow to USD 1.63 billion in 2025, with a CAGR of 6.17%, reaching USD 2.21 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.54 billion
Estimated Year [2025] USD 1.63 billion
Forecast Year [2030] USD 2.21 billion
CAGR (%) 6.17%

In the rapidly evolving realm of healthcare, digital diagnostics are redefining the way diseases are detected and managed. Recent advances in artificial intelligence, imaging technology, and molecular genetics underline a transformative era where diagnostic methodologies are becoming increasingly effective and precise. This evolution is spurred by an amalgamation of cross-disciplinary research and technological breakthroughs that integrate digital capabilities into conventional diagnostic procedures. The strategic interplay between technology developers and clinical practitioners is catalyzing innovations that not only optimize diagnostic accuracy but also enhance patient outcomes across multiple clinical conditions.

In this context, stakeholders ranging from industry experts to healthcare decision-makers have turned their attention to the critical role played by digital diagnostics in reshaping patient care pathways. Much like a carefully orchestrated symphony, the integration of emerging digital tools with traditional methodologies is crafting a future where early detection, personalized treatment, and improved disease management stand as achievable goals. These changes are particularly significant in settings where rapid diagnosis is paramount, thereby laying the foundation for a global shift towards data-driven medical decision-making.

This comprehensive overview captures the multifaceted dimensions of the digital diagnostics market, providing pertinent insights into market trends, transformative shifts, segmentation analyses, and regional variations. The following sections delve deeper into the catalysts driving market evolution and present a detailed narrative on both the opportunities and challenges that define this vital sector.

Transformative Shifts Redefining the Digital Diagnostics Landscape

The landscape of digital diagnostics has experienced unprecedented transformation over the past few years. Emerging technologies are bridging the gap between diagnostic imaging, real-time patient monitoring, and precise molecular analysis. One of the most notable shifts is the increasing integration of advanced analytics into diagnostic practices. Enhanced imaging technologies and machine learning algorithms are now key drivers, enabling more accurate and faster disease identification. Innovations in data processing and cloud connectivity have also paved the way for increased collaboration across different geographic regions and research institutions.

Additionally, the convergence of mobile health applications with sophisticated diagnostic equipment is making it easier to deliver healthcare services to remote and underserved areas. This evolution not only democratizes access to state-of-the-art diagnostic tools but also reduces the time elapsed between initial consultation and confirmatory diagnosis. Digital pathology, radiology, and wearable health monitoring systems are now central to an ecosystem designed to revolutionize traditional care models. With ongoing investments in research and a strong regulatory focus, the market is witnessing a steady transition toward early disease detection and personalized treatment strategies.

As the healthcare industry moves from reactive to proactive care, such trends underscore the importance of embracing digital transformation. The synergy between data science and traditional diagnostics is creating a resilient framework that can adapt to emerging health threats and shifting patient needs, ensuring a robust and scalable future for healthcare delivery.

Key Segmentation Insights Revealing Market Nuances

Detailed segmentation analysis offers a nuanced perspective into the underlying dynamics of the digital diagnostics market. When evaluating the market based on type, extensive studies reveal a division into digital dermatology, digital pathology, digital radiology, mobile health diagnostics, molecular and genetic diagnostics, and wearable and remote monitoring. This categorization highlights both the technical advancements and the growing integration of digital methodologies into every facet of diagnostic processes.

Further, a look into industry applications reveals that digital diagnostics are increasingly influencing the way we approach treatment in areas such as cardiology, infectious diseases, neurology, and oncology. These areas represent not only a broad spectrum of medical challenges but also capture the key opportunities for growth through enhanced diagnostic precision and early intervention. Complementing these insights, the segmentation based on end-user demographics pinpoints the critical roles played by diagnostic laboratories and imaging centers, hospitals and clinics, and research institutes alongside academic medical centers. Each of these segments contributes uniquely to the overall market landscape by leveraging specialized digital tools to address specific medical requirements.

The deliberate dissection of market segments facilitates a clearer understanding of the evolving demand, driving innovations that cater to tailored diagnostic needs. Hence, by interweaving insights from various segmentation perspectives, stakeholders can better strategize product development, market entry tactics, and resource allocations, thereby ensuring that technological advancements are effectively aligned with clinical priorities and patient care standards.

Based on Type, market is studied across Digital Dermatology, Digital Pathology, Digital Radiology, Mobile Health (mHealth) Diagnostics, Molecular & Genetic Diagnostics, and Wearable & Remote Monitoring.

Based on Industry Applications, market is studied across Cardiology, Infectious Diseases, Neurology, and Oncology.

Based on End-User, market is studied across Diagnostic Laboratories & Imaging Centers, Hospitals & Clinics, and Research Institutes & Academic Medical Centers.

Key Regional Insights Shaping Global Market Trends

Regional dynamics play a pivotal role in dictating the pace and direction of the digital diagnostics market. In the Americas, technological advancements and a strong focus on healthcare innovation create a fertile environment for the adoption of digital solutions. This region benefits from extensive research and high capital investments, leading to rapid market penetration and significant improvements in public health outcomes.

Europe, Middle East & Africa exhibit unique patterns driven by diverse regulatory landscapes, varying levels of technological adoption, and distinct demographic challenges. Regulatory frameworks here are increasingly adapting to integrate digital health trends into clinical practice, providing new avenues for market expansion and horizontal growth in services.

Meanwhile, Asia-Pacific stands out as a region with immense growth potential. The confluence of a large population base, increasing healthcare expenditures, and government initiatives targeted at digital transformation accelerates the demand for innovative diagnostics. These regional insights collectively underscore the importance of tailoring digital diagnostic strategies to local market conditions, ensuring that technological leaps in one part of the world can serve as blueprints for innovations elsewhere.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Digital Diagnostics Frontier

Market leadership in digital diagnostics is strongly influenced by several high-impact companies. Giants like Abbott Laboratories and Agilent Technologies are pioneering the integration of robust hardware with sophisticated digital solutions. Companies such as Aidoc and Becton, Dickinson, and Company have demonstrated the power of artificial intelligence to transform diagnostic imaging and workflow efficiencies in clinical settings. Bio-Rad Laboratories, along with Butterfly Network, inc, are advancing how diagnostics are conducted by incorporating genomic insights with digital platforms.

Established names like CANON MEDICAL SYSTEMS CORPORATION and Carestream Health, Inc. continue to contribute significantly by refining imaging technology and diagnostic software. Firms such as Danaher Corporation and FUJIFILM Holdings America Corporation have accelerated the adoption of digital pathology and radiology systems; while GE Healthcare Technologies, Inc. and Google LLC are setting benchmarks for innovative integration of digital ecosystems in healthcare.

Additionally, Guardant Health, Inc., Hologic, Inc., and International Business Machines Corp. are noteworthy for harnessing data analytics to improve diagnostic precision. Invitae Corporation, Koninklijke Philips N.V., and Microsoft Corporation have also been central to pushing the boundaries in areas such as molecular diagnostics and remote health monitoring. In recent years, companies like NVIDIA Corporation, PathAI, Inc., Qiagen N.V., and Roche Diagnostics Corporation have emerged as frontrunners by merging computational advancements with traditional diagnostics. This trend is further bolstered by Siemens Healthineers, Tempus AI, Inc., and Thermo Fisher Scientific, whose commitment to continuous innovation enables the market to progress toward more personalized, accurate, and efficient diagnostic solutions.

The report delves into recent significant developments in the Digital Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Aidoc, Becton, Dickinson, and Company, Bio-Rad Laboratories, Butterfly Network, inc, CANON MEDICAL SYSTEMS CORPORATION, Carestream Health, Inc., Danaher Corporation, FUJIFILM Holdings America Corporation, GE Healthcare Technologies, Inc., Google LLC, Guardant Health, Inc., Hologic, Inc., International Business Machines Corp., Invitae Corporation, Koninklijke Philips N.V., Microsoft Corporation, NVIDIA Corporation, PathAI, Inc., Qiagen N.V., Roche Diagnostics Corporation, Siemens Healthineers, Tempus AI, Inc., and Thermo Fisher Scientific. Actionable Recommendations for Industry Leaders Seeking Competitive Advantage

Leaders looking to leverage digital diagnostics should prioritize strategic investments in research and development to harness new technological advances. Emphasizing collaboration between technology innovators and clinical experts ensures that product development is not only forward-thinking but also closely aligned with patient care needs. It is imperative for organizations to cultivate agile frameworks that enable quick adaptation to technological disruptions and regulatory shifts.

Furthermore, enhancing data integration capabilities across various diagnostic touchpoints will streamline operations and improve the accuracy of clinical decisions. Investing in robust cybersecurity measures is another critical area, as trust becomes an increasingly valued asset in the digital diagnostics arena. Such a focus not only protects sensitive patient data but also enhances overall system reliability and stakeholder confidence.

Developing comprehensive training programs for medical personnel on the new digital tools can smooth the transition to technology-based diagnostics and maximize the return on investment. Additionally, continuous evaluation of market trends and patient needs will empower organizations to align their strategies effectively. By adopting a proactive and forward-looking stance, industry leaders can effectively navigate challenges while capitalizing on emerging market opportunities.

Conclusion: Navigating the Future of Digital Diagnostics with Confidence

The digital diagnostics market stands at the intersection of innovation and clinical excellence. As advanced imaging, real-time monitoring, and digital integration continue to reshape healthcare, it becomes essential for both clinicians and technologists to adopt a unified approach to in-depth diagnostics. The blend of technology and medicine is setting a new benchmark in patient care, offering unprecedented opportunities for early detection, personalized treatments, and finally, improved patient outcomes.

A comprehensive assessment of market segments, regional dynamics, and competitive landscapes reveals a resilient market designed for sustainable growth. Stakeholders who proactively adapt to these shifts are well-positioned to lead this technological revolution and drive the future of healthcare forward. The combined efforts and innovative spirit among industry players herald a promising era where digital solutions empower both clinicians and patients alike, thereby forging a path to a smarter, more efficient healthcare system.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Favorable government policies and regulatory support providing significant impetus to digital diagnostics
      • 5.1.1.2. Increased adoption of telemedicine and remote monitoring solutions fostering digital diagnostics integration
      • 5.1.1.3. Growing prevalence of chronic diseases requiring early detection and precise diagnostic solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with advanced technology implementation and expert workforce training
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of personalized medicine through digital diagnostics by integrating wearable technology
      • 5.1.3.2. Strategic partnerships and collaborations streamlining digital diagnostic workflows with advanced data analytics
    • 5.1.4. Challenges
      • 5.1.4.1. Data privacy concerns and cybersecurity risks undermining consumer trust
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing demand for mobile health (mHealth) diagnostics leveraging smartphone connectivity and portable devices
    • 5.2.2. End-User: Rising application of digital diagnostics in diagnostic laboratories & imaging centers for intelligence-driven analytics to meet these stringent requirements
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Diagnostics Market, by Type

  • 6.1. Introduction
  • 6.2. Digital Dermatology
  • 6.3. Digital Pathology
  • 6.4. Digital Radiology
  • 6.5. Mobile Health (mHealth) Diagnostics
  • 6.6. Molecular & Genetic Diagnostics
  • 6.7. Wearable & Remote Monitoring

7. Digital Diagnostics Market, by Industry Applications

  • 7.1. Introduction
  • 7.2. Cardiology
  • 7.3. Infectious Diseases
  • 7.4. Neurology
  • 7.5. Oncology

8. Digital Diagnostics Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories & Imaging Centers
  • 8.3. Hospitals & Clinics
  • 8.4. Research Institutes & Academic Medical Centers

9. Americas Digital Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Digital Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Digital Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. FPNV Positioning Matrix, 2024
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. PocDoc secures GBP 5 million in pre-series A funding to expand its app-based digital diagnostics platform
    • 12.3.2. Digital Diagnostics teams with Google Cloud to accelerate diabetic retinopathy testing in Saudi Arabia
    • 12.3.3. Roche expands digital pathology by integrating over 20 AI algorithms from new collaborators to transform cancer diagnostics
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies
  • 3. Aidoc
  • 4. Becton, Dickinson, and Company
  • 5. Bio-Rad Laboratories
  • 6. Butterfly Network, inc
  • 7. CANON MEDICAL SYSTEMS CORPORATION
  • 8. Carestream Health, Inc.
  • 9. Danaher Corporation
  • 10. FUJIFILM Holdings America Corporation
  • 11. GE Healthcare Technologies, Inc.
  • 12. Google LLC
  • 13. Guardant Health, Inc.
  • 14. Hologic, Inc.
  • 15. International Business Machines Corp.
  • 16. Invitae Corporation
  • 17. Koninklijke Philips N.V.
  • 18. Microsoft Corporation
  • 19. NVIDIA Corporation
  • 20. PathAI, Inc.
  • 21. Qiagen N.V.
  • 22. Roche Diagnostics Corporation
  • 23. Siemens Healthineers
  • 24. Tempus AI, Inc.
  • 25. Thermo Fisher Scientific

LIST OF FIGURES

  • FIGURE 1. DIGITAL DIAGNOSTICS MARKET MULTI-CURRENCY
  • FIGURE 2. DIGITAL DIAGNOSTICS MARKET MULTI-LANGUAGE
  • FIGURE 3. DIGITAL DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 4. DIGITAL DIAGNOSTICS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 15. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. DIGITAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 23. DIGITAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DIGITAL DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIGITAL DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIGITAL RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY MOBILE HEALTH (MHEALTH) DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR & GENETIC DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY WEARABLE & REMOTE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES & IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES & ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. DIGITAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 151. DIGITAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024